Skip to main content
OpenTrials
Completed

NCT Number: NCT03360162

Velocimetric Study of Temporal Arteries in Patients With Horton Disease Using Scan-Doppler

The use of ultrasonography in detecting giant cell arteritis ( GCA) is emerging. Currently, temporal biopsy is the gold standard to diagnose GCA but studies have shown the interest to use B mode ultrasonography. However, until now, the study of velocities in GCA have not been yet performed.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patients with suspicious giant arteritis

Exclusion criteria

  • patients who have already been treated or diagnosed for giant arteritis

Treatment and study plan

Primary outcomes

  1. Velocimetric Study of Temporal Arteries in Patients With Horton Disease Using Scan-Doppler

    Time frame: 2 months

    velocimetric temporal arterial study in giant arteritis

Secondary outcomes

  1. evaluation of the halo sign in giant arteritis using B mode ultrasonography

    Time frame: 2 months

    presence or absence of the halo sign in giant arteritis patients

Sponsors and collaborators

Lead sponsor

University Hospital, Brest

Other

Registry information

Acronym: VELHOR

Important dates

Study start
2017
Primary completion
2017
Study completion
2017
First posted
Dec 4, 2017
Registry last updated
Apr 21, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.